Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,565 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05683730Recruiting
Intermittent calorie restriction for mild to moderate Crohn’s
This trial studies whether planned periods of eating fewer calories can help people with mild to moderate Crohn’s disease. It requires stable Crohn’s treatment and monitoring for weight and health changes during the study.
Vandœuvre-lès-Nancy, CHRU de NancyAges 18–65 - NCT05665556Recruiting
Registry for pulmonary hypertension in connective tissue disease
This trial is a registry that collects health information from people with certain types of pulmonary hypertension linked to connective tissue diseases. It helps doctors understand patterns of disease and outcomes, which can guide future care and studies.
Mexico CityAges 18 years+ - NCT05942729Recruiting
Checking heart disease diagnosis using echo images and health data
This study looks at how well heart ultrasound (echocardiography) images and clinical information can be used to diagnose cardiac conditions. If you have a clear ultrasound study already or can get one with good image quality, your information may help improve diagnostic accuracy.
Pierre-BéniteAges 18 years+ - NCT05946512Recruiting
Yoga breathing plus lung MRI measurements for post-COVID symptoms
This study uses breathing exercises from yoga and MRI (a scan of the body) measurements to see how well yoga breathing can improve ongoing breathing symptoms after COVID-19. It also compares results in a few other specific groups and healthy volunteers.
Innsbruck, TyrolAges 18–50 - NCT05154370Recruiting
Registry for neuroinflammation diseases and diagnosis categories
This study is a registry that collects information from people diagnosed with certain neuroinflammation conditions. It may help doctors learn how these diseases behave over time and support future research.
Beijing, Beijing MunicipalityAges Any age - NCT05701293Recruiting
RenZan stent check for leg artery narrowing
This trial follows how well the RenZan stent works and how safe it is for people with blocked or badly narrowed thigh-to-knee leg arteries. It may help by improving blood flow and adding careful monitoring to see how outcomes compare over time.
SienaAges 18 years+ - NCT02060565Recruiting
Test noninvasive scans to diagnose chronic liver disease
This study looks at how well noninvasive tests (tests that don’t require surgery, like scans and blood-based measurements) can diagnose chronic liver disease in people with certain liver conditions. It may help doctors choose better, less invasive ways to identify the type and stage of liver problems.
PessacAges 18 years+ - NCT05965128Recruiting
Testing a new 3-step diagnosis for fever and lung infections
This study tests a new, step-by-step way doctors identify what’s causing sudden fever and respiratory infections (like pneumonia or flu-like illness). It may help clinicians diagnose faster and choose the right next care.
Lanzhou, GansuAges 12–100 - NCT05981950Recruiting
AI for diagnosing retinal diseases in real-world settings
This study tests how well an AI system can diagnose retinal diseases from eye photos. It might help if you need a quick and accurate diagnosis using standard eye imaging.
Beijing, Beijing MunicipalityAges 1–100 - NCT05996211Recruiting
Swiss Study on Brain Development in Children with Heart Defects
This study follows children with severe heart problems born recently to see how their brain development progresses. It helps doctors understand what support these children might need as they grow.
BernAges 1 week–1 month - NCT05985213Recruiting
Brain blood vessel disease study at Yueyang Hospital
This study follows people with small vessel brain disease to understand how it changes over time. You may join if you've had an MRI showing this type of brain change and are able to take care of yourself daily.
ShanghaiAges 18–80 - NCT06004544Recruiting
Heart screening in pregnant women without symptoms
This study uses echocardiography (an ultrasound of the heart) to check for hidden heart problems in pregnant women who do not have any symptoms. It aims to find issues early and improve care.
Karachi, SindhAges Any age - NCT00573027Recruiting
Study of heart pain from small artery heart disease
This trial studies people who have chest pain (angina) due to problems with the heart’s small arteries, not a big blockage. It aims to test whether treatment approaches can help these patients by better understanding the cause of their heart-related symptoms.
Los Angeles, CaliforniaAges 18 years+ - NCT04318119Recruiting
Brain scan registry for small blood vessel disease
This study is a registry that collects information and brain scan findings from adults with possible small vessel disease. It may help doctors better understand how this condition looks on scans and what it is linked to.
Fuzhou, FujianAges 18–100 - NCT05697991Recruiting
Study of fatty liver in adults with type 2 diabetes
This study looks at people with type 2 diabetes who also have fatty liver. The goal is to learn more about this condition in a Saudi group and test approaches that could improve care.
Riyadh, Select A State Or ProvinceAges 18–60 - NCT05984524Recruiting
Gamma music therapy for mild Alzheimer's disease
This study tests whether a specially designed music intervention can help people with mild Alzheimer's disease. You listen to music with a gamma frequency beat, which may improve brain function and memory.
Boston, MassachusettsAges 50–95 - NCT06074731Recruiting
Eye imaging study using a new scanner
This trial uses a special eye scanner to look at eye diseases. It might help doctors see eye problems more clearly.
Linz, Upper AustriaAges 5–110 - NCT06069232Recruiting
Aortic valve disease risk and prognosis study
This study is looking at people with aortic valve disease to understand what factors affect their risk and to build a model that predicts how the disease will progress. Researchers hope this will help doctors better care for patients in the future.
Guangzhou, GuangdongAges 18–100 - NCT06090682Recruiting
Brain stimulation for Parkinson's with thinking problems
This trial tests a brain stimulation technique (deep brain stimulation) to see if it can help people with Parkinson's disease who also have mild cognitive problems. The goal is to understand how stimulation affects both movement and thinking.
Tianjin, Tianjin MunicipalityAges Up to 75 years - NCT04087031Recruiting
Tech-based rehab for early Parkinson’s symptoms in older adults
This trial tests an innovative, technology-supported rehabilitation program to help older adults with early-stage Parkinson’s disease improve daily function. It may be helpful if your symptoms are mild and your treatments have been stable for at least a month.
AnconaAges 65 years+ - NCT05573802RecruitingPhase 1/Phase 2
Belantamab and other medicines for new multiple myeloma
This early-phase study tests how safe and effective belantamab mafodotin is when combined with lenalidomide and dexamethasone, plus a medicine called nirogacestat, in people with newly diagnosed multiple myeloma who cannot have stem cell transplant. It may help shrink the cancer and improve outcomes, while doctors track side effects.
AthensAges 18 years+ - NCT06026436Recruiting
Predicting clot and bleeding risk in kidney disease patients after a heart attack
This trial tests whether a blood test looking at platelets and tiny cell particles can help predict future blood clots or bleeding in people who have both chronic kidney disease and a recent heart attack. The goal is to improve treatment safety.
MarseilleAges 18–90 - NCT05194787Recruiting
Online tests to spot early Alzheimer’s changes
This study looks at whether online motor (movement) and thinking tasks can detect early changes related to Alzheimer’s disease. You may be able to take part if you’re over 50 and do not already have a diagnosis of dementia.
Hobart, TasmaniaAges 50 years+ - NCT05494060RecruitingPhase 2
Adjuvant chemo plus immunotherapy for ctDNA-positive stomach cancer
This trial tests whether adding an anti-cancer immune treatment and another targeted drug to standard chemotherapy after surgery can lower the chance of cancer coming back. It is for people whose blood test (ctDNA) shows leftover cancer-related DNA after surgery.
Nanjing, JiangsuAges 18–75
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,565 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.